Skip to main content
Erschienen in: Annals of Surgical Oncology 1/2012

01.01.2012 | Gynecologic Oncology

Reduction/Prevention of Lower Extremity Lymphedema after Pelvic and Para-aortic Lymphadenectomy for Patients with Gynecologic Malignancies

verfasst von: Hitoshi Hareyama, MD, Kumiko Ito, MD, Kenichi Hada, MD, Akiko Uchida, MD, Yukitoki Hayakashi, MD, Emi Hirayama, MD, Mamoru Oikawa, MD, Kazuhiko Okuyama, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Lower extremity lymphedema (LEL) is a serious complication caused by lymphadenectomy in patients with gynecologic malignancies. In this study, we evaluated the effect of preserving the circumflex iliac lymph nodes (CILNs), i.e., the most caudal external iliac lymph nodes, for the prevention and reduction of LEL by comparing two groups of patients, one in which CILN were removed and the other in which CILNs were preserved.

Methods

We retrospectively reviewed 329 patients with gynecologic malignancies who had undergone abdominal complete systematic pelvic and para-aortic lymphadenectomy. The patients were divided into nonpreserved (n = 189) and preserved (n = 140) groups, depending on whether CILNs were removed. Primary outcome measures included the incidence and severity of LEL.

Results

The incidence of LEL was significantly lower in the preserved group than in the nonpreserved group (P < 0.0001). The frequency of LEL was also significantly lower in the preserved group than in the nonpreserved group regardless of the range of pelvic and para-aortic lymphadenectomy (P < 0.0001). LEL in the overwhelming majority of cases in the preserved group was mild, and no patients experienced severe LEL. Further, the incidence of cellulitis was 0% in the preserved group, while it was 12.7% in the nonpreserved group (P < 0.0001). Lymphoscintigraphy revealed collateral pathways from the preserved CILN along the iliac and large abdominal vessels.

Conclusions

This method of lymph node preservation is a simple and extremely effective approach for preventing/reducing LEL after pelvic and para-aortic lymphadenectomy for patients with gynecologic malignancies.
Literatur
1.
Zurück zum Zitat Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg. 2007;59:464–72.PubMedCrossRef Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg. 2007;59:464–72.PubMedCrossRef
2.
Zurück zum Zitat Abu-Rustum NR, Barakat RR. Observations on the role of circumflex iliac node resection and the etiology of lower extremity lymphedema following pelvic lymphadenectomy for gynecologic malignancy. Gynecol Oncol. 2007;106:4–5.PubMedCrossRef Abu-Rustum NR, Barakat RR. Observations on the role of circumflex iliac node resection and the etiology of lower extremity lymphedema following pelvic lymphadenectomy for gynecologic malignancy. Gynecol Oncol. 2007;106:4–5.PubMedCrossRef
3.
Zurück zum Zitat Standring S. Gray’s anatomy: the anatomical basis of clinical practice. 39th ed. New York: Elsevier Churchill Livingstone; 2005. Standring S. Gray’s anatomy: the anatomical basis of clinical practice. 39th ed. New York: Elsevier Churchill Livingstone; 2005.
4.
Zurück zum Zitat Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in stage IB, IIA and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999;85:1547–54.PubMedCrossRef Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in stage IB, IIA and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999;85:1547–54.PubMedCrossRef
5.
Zurück zum Zitat Tsumura N, Sakuragi N, Hareyama H, et al. The distribution pattern and risk factors of pelvic and paraaortic lymph node metastasis in epithelial ovarian carcinoma. Int J Cancer. 1998;79:526–30.PubMedCrossRef Tsumura N, Sakuragi N, Hareyama H, et al. The distribution pattern and risk factors of pelvic and paraaortic lymph node metastasis in epithelial ovarian carcinoma. Int J Cancer. 1998;79:526–30.PubMedCrossRef
6.
Zurück zum Zitat International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphlogy. Lymphology. 2003;36:84-91. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphlogy. Lymphology. 2003;36:84-91.
7.
Zurück zum Zitat Abu-Rustum NR, Alektiar K, Iasonos A, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Ketterring Cancer Center. Gynecol Oncol. 2006;103:714–8.PubMedCrossRef Abu-Rustum NR, Alektiar K, Iasonos A, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Ketterring Cancer Center. Gynecol Oncol. 2006;103:714–8.PubMedCrossRef
8.
Zurück zum Zitat Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer. 2006;16:1130–9.PubMedCrossRef Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer. 2006;16:1130–9.PubMedCrossRef
9.
Zurück zum Zitat Tada H, Teramukai S, Fukushima M, Sasaki H. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer. 2009;9:1–6.CrossRef Tada H, Teramukai S, Fukushima M, Sasaki H. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer. 2009;9:1–6.CrossRef
10.
Zurück zum Zitat Tanaka T, Ohki N, Kojima A, et al. Radiotherapy negates the effect of retroperitoneal non closure for prevention of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey. Int J Gynecol Cancer. 2007;17:460–4.PubMedCrossRef Tanaka T, Ohki N, Kojima A, et al. Radiotherapy negates the effect of retroperitoneal non closure for prevention of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey. Int J Gynecol Cancer. 2007;17:460–4.PubMedCrossRef
11.
Zurück zum Zitat Soisson AP, Soper JT, Clarke-Pearson DL, Berchuck A, Montana G, Creasman WT. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol. 1990;37:390–5.PubMedCrossRef Soisson AP, Soper JT, Clarke-Pearson DL, Berchuck A, Montana G, Creasman WT. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol. 1990;37:390–5.PubMedCrossRef
12.
Zurück zum Zitat Chatani M, Nose T, Masaki N, Inoue T. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications. Strahlenther Onkol. 1998;174:504–9.PubMedCrossRef Chatani M, Nose T, Masaki N, Inoue T. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications. Strahlenther Onkol. 1998;174:504–9.PubMedCrossRef
13.
Zurück zum Zitat Manchana T, Sirisabya N, Lertkhachonsuk R, et al. Long term complications after radical hysterectomy with pelvic lymphadenectomy. J Med Assoc Thai. 2009;92:451–6.PubMed Manchana T, Sirisabya N, Lertkhachonsuk R, et al. Long term complications after radical hysterectomy with pelvic lymphadenectomy. J Med Assoc Thai. 2009;92:451–6.PubMed
14.
Zurück zum Zitat Mortimer PS. American Cancer Society Lymphedema Workshop: the pathophysiology of lymphedema. Cancer. 1998;83:2798–802.PubMedCrossRef Mortimer PS. American Cancer Society Lymphedema Workshop: the pathophysiology of lymphedema. Cancer. 1998;83:2798–802.PubMedCrossRef
15.
Zurück zum Zitat Lea JS, Sheet EE, Duska LR, Miller DS, Schorge JO. Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection. Gynecol Oncol. 2002;84:285–8.PubMedCrossRef Lea JS, Sheet EE, Duska LR, Miller DS, Schorge JO. Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection. Gynecol Oncol. 2002;84:285–8.PubMedCrossRef
16.
Zurück zum Zitat Kim SM, Choi HS, Byun JS. Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer. 2000;10:305–12.PubMedCrossRef Kim SM, Choi HS, Byun JS. Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer. 2000;10:305–12.PubMedCrossRef
17.
Zurück zum Zitat Rob L, Strmad P, Robova H, et al. Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. Gynecol Oncol. 2005;98:281–8.PubMedCrossRef Rob L, Strmad P, Robova H, et al. Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. Gynecol Oncol. 2005;98:281–8.PubMedCrossRef
18.
Zurück zum Zitat Mohan DS, Samuels MA, Selim MA, Shalodi AD, Ellis RJ, Yun HJ. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol. 1998;70:165–71.PubMedCrossRef Mohan DS, Samuels MA, Selim MA, Shalodi AD, Ellis RJ, Yun HJ. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol. 1998;70:165–71.PubMedCrossRef
19.
Zurück zum Zitat Cho H, Kim YT, Kim JH. Accuracy of preoperative tests in clinical stage I endometrial cancer: the importance of lymphadenectomy. Acta Obstet Gynecol. 2010;89:175–81.CrossRef Cho H, Kim YT, Kim JH. Accuracy of preoperative tests in clinical stage I endometrial cancer: the importance of lymphadenectomy. Acta Obstet Gynecol. 2010;89:175–81.CrossRef
20.
Zurück zum Zitat Lo KWK, Cheung TH, Yu MY, Yim SF, Chung TK. The value of pelvic and para-aortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy. Int J Gynecol Cancer. 2003;13:863–9.PubMedCrossRef Lo KWK, Cheung TH, Yu MY, Yim SF, Chung TK. The value of pelvic and para-aortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy. Int J Gynecol Cancer. 2003;13:863–9.PubMedCrossRef
21.
Zurück zum Zitat Panici PB, Maggioni A, Hacker N, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005;97:560–6.PubMedCrossRef Panici PB, Maggioni A, Hacker N, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005;97:560–6.PubMedCrossRef
22.
Zurück zum Zitat Onda T, Yoshikawa H, Mizutani K, et al. Treatment of node-positive endometrial cancer with complete node resection, chemotherapy and radiation therapy. Int J Cancer. 1997;75:1836–41. Onda T, Yoshikawa H, Mizutani K, et al. Treatment of node-positive endometrial cancer with complete node resection, chemotherapy and radiation therapy. Int J Cancer. 1997;75:1836–41.
23.
Zurück zum Zitat Füller J, Guderian D, Köhler C, Schneider A, Wendt TG. Lymph edema of the lower extremities after lymphadenectomy and radiotherapy for cervical cancer. Strahlenther Onkol. 2008;184:206–11.PubMedCrossRef Füller J, Guderian D, Köhler C, Schneider A, Wendt TG. Lymph edema of the lower extremities after lymphadenectomy and radiotherapy for cervical cancer. Strahlenther Onkol. 2008;184:206–11.PubMedCrossRef
24.
Zurück zum Zitat Clouse ME. Clinical lymphography. In: Taveras JM, Wood EH, editors. Golden’s diagnostic radiology. Baltimore: Williams and Wilkins; 1977. p. 14–60. Clouse ME. Clinical lymphography. In: Taveras JM, Wood EH, editors. Golden’s diagnostic radiology. Baltimore: Williams and Wilkins; 1977. p. 14–60.
25.
Zurück zum Zitat Pecking AP, Albérini JL, Wartski M, Edeline V, Cluzan RV. Relationship between lymphoscintigraphy and clinical findings in lower limb lymphedema (LO): toward a comprehensive staging. Lymphology. 2008;41:1–10.PubMed Pecking AP, Albérini JL, Wartski M, Edeline V, Cluzan RV. Relationship between lymphoscintigraphy and clinical findings in lower limb lymphedema (LO): toward a comprehensive staging. Lymphology. 2008;41:1–10.PubMed
26.
Zurück zum Zitat Hirahatake K, Hareyama H, Sakuragi N, Nishiya M, Makinoda S, Fujimoto S. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol. 1997;65:82–7.PubMedCrossRef Hirahatake K, Hareyama H, Sakuragi N, Nishiya M, Makinoda S, Fujimoto S. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol. 1997;65:82–7.PubMedCrossRef
27.
Zurück zum Zitat Takeshima N, Hirai Y, Umayahara K, Fujiwara K, Takizawa K, Hasumi K. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumor. Gynecol Oncol. 2005;99:427–31.PubMedCrossRef Takeshima N, Hirai Y, Umayahara K, Fujiwara K, Takizawa K, Hasumi K. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumor. Gynecol Oncol. 2005;99:427–31.PubMedCrossRef
28.
Zurück zum Zitat Brennan MJ, Miller LT. American Cancer Society Lymphedema Workshop: overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer. 1998;83:2821–7.PubMedCrossRef Brennan MJ, Miller LT. American Cancer Society Lymphedema Workshop: overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer. 1998;83:2821–7.PubMedCrossRef
29.
Zurück zum Zitat Narushima M, Mihara M, Yamamoto Y, Iida T, Koshima I, Mundinger GS. The intravascular stenting method for treatment of extremity lymphedema with multiconfiguration lymphaticovenous anastomoses. Plast Reconstr Surg. 2010;125:935–43.PubMedCrossRef Narushima M, Mihara M, Yamamoto Y, Iida T, Koshima I, Mundinger GS. The intravascular stenting method for treatment of extremity lymphedema with multiconfiguration lymphaticovenous anastomoses. Plast Reconstr Surg. 2010;125:935–43.PubMedCrossRef
30.
Zurück zum Zitat Assouad J, Becker C, Hidden G, Riquet M. The cutaneo-lymph node flap of the superficial circumflex artery. Surg Radiol Anat. 2002;24:87–90.PubMedCrossRef Assouad J, Becker C, Hidden G, Riquet M. The cutaneo-lymph node flap of the superficial circumflex artery. Surg Radiol Anat. 2002;24:87–90.PubMedCrossRef
31.
Zurück zum Zitat Patsner B, Hackett TE. Use of the omental J-flap for prevention of postoperative complications following radical abdominal hysterectomy: report of 140 cases and literature review. Gynecol Oncol. 1997;65:405–7.PubMedCrossRef Patsner B, Hackett TE. Use of the omental J-flap for prevention of postoperative complications following radical abdominal hysterectomy: report of 140 cases and literature review. Gynecol Oncol. 1997;65:405–7.PubMedCrossRef
32.
Zurück zum Zitat Logmans A, Kruyt RH, de Bruin HG, Cox PH, Pillary M, Trimbos JB. Lymphedema and lymphocysts following lymphadenectomy may be prevented by omentoplasty: a pilot study. Gynecol Oncol. 1999;75:323–7.PubMedCrossRef Logmans A, Kruyt RH, de Bruin HG, Cox PH, Pillary M, Trimbos JB. Lymphedema and lymphocysts following lymphadenectomy may be prevented by omentoplasty: a pilot study. Gynecol Oncol. 1999;75:323–7.PubMedCrossRef
Metadaten
Titel
Reduction/Prevention of Lower Extremity Lymphedema after Pelvic and Para-aortic Lymphadenectomy for Patients with Gynecologic Malignancies
verfasst von
Hitoshi Hareyama, MD
Kumiko Ito, MD
Kenichi Hada, MD
Akiko Uchida, MD
Yukitoki Hayakashi, MD
Emi Hirayama, MD
Mamoru Oikawa, MD
Kazuhiko Okuyama, MD
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 1/2012
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1863-4

Weitere Artikel der Ausgabe 1/2012

Annals of Surgical Oncology 1/2012 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.